Open Terminal →

Analyses / XOM

XOM Exxonmobil Holdings Corp As of Nov 19, 2026
$160.58

Mixed read: shares sit in the upper-middle of their 52-week range, but revenue and EPS are contracting per provider data.

Setup: Recovery / value-leaning, with a weak earnings trend Confidence: medium Horizon: 1-3 months Risk: medium Category: Large Cap
🔒 Trade Plan — entry · target · stop
Entry Zone
$•••–•••
Target
$•••
Stop Loss
$•••
Risk / Reward
•.• : 1
Unlock the exact levels — free →

A free account reveals XOM's entry zone, price target & stop loss. Full 1-week to 1-year price forecasts are included with Pro.

The Thesis

▲ Bull Case

Shares trade about 62% of the way up the 52-week range, well above the 114.19 low. Trailing P/E is 16.4x, EV/EBITDA 11.9x, dividend yield 2.52% with a 59.7% payout, and beta 0.19 (low sensitivity to the broad market). Provider five-year revenue growth is 12.65%. In the provider insider sample, shares bought (1,051,335) far exceed shares sold (150,164). If revenue growth turns positive from -6.69%, the trailing multiple could look less stretched.

▼ Bear Case

Revenue growth is -6.69% and EPS growth is -20.34%. Forward P/E of 23.1x sits above trailing 16.4x, which implies the market expects lower earnings. Price-to-FCF of 28.2x is elevated. Shares fell 3.97% on the day to 160.58, below the 167.21 prior close and near the 160.55 session low. ROE, ROIC, debt-to-equity and RSI are unavailable, so balance-sheet and momentum checks are incomplete.

Valuation

FAIRLY PRICED — score 52/100

Trailing multiples look moderate, but forward P/E and price-to-FCF are higher, and earnings and revenue are falling.

Technical Levels

Support · $160.55 (Session low) · $154.00 (Scenario entry floor) · $114.19 (52-week low)

Resistance · $167.21 (Prior close) · $166.96 (Session high) · $188.50 (52-week high)

RSI: unavailable

Financial Health

Score 55/100. Liquidity ratios are adequate but not strong. Debt and coverage data are missing, so solvency cannot be fully assessed.

Catalysts

No dated earnings or company event in the payloadunknownunknown
Insider and ETF flow headlines in recent newsrecentlow

Risk Flags

Revenue growth -6.69% and EPS growth -20.34% (provider).
Fundamentals, balance sheet and cash flow sections are null in the payload.
ROE, ROIC, debt-to-equity and interest coverage are unavailable.
RSI is unavailable, so momentum reading is incomplete.
Insider transaction counts are 25 buys and 25 sells; form types not provided.
News timestamps look unusually recent; verify dates before relying on them.

See XOM's full trade plan — free

Create a free account to unlock the exact entry, target, and stop — plus run live analysis on any of 5,000+ tickers. No card required.

Unlock XOM free →

Recent News

More Analyses

XOM FAQ

Is XOM a buy right now?

Exxonmobil Holdings Corp's current read is a Recovery / value-leaning, with a weak earnings trend setup with medium confidence over a 1-3 months horizon. Valuation: FAIRLY PRICED. See the full bull and bear case above, or run a live analysis for the exact entry, target and stop.

Is XOM overvalued?

FAIRLY PRICED (valuation score 52/100). Trailing multiples look moderate, but forward P/E and price-to-FCF are higher, and earnings and revenue are falling.

What are the risks of buying XOM?

Revenue growth is -6.69% and EPS growth is -20.34%. Forward P/E of 23.1x sits above trailing 16.4x, which implies the market expects lower earnings. Price-to-FCF of 28.2x is elevated. Shares fell 3.97% on the day to 160.58, below the 167.21 prior close and near the 160.55 session low. ROE, ROIC, debt-to-equity and RSI are unavailable, so balance-sheet and momentum checks are incomplete.